ESG Report

Overview

The report highlights Moderna's 2022 global-health expansion, with 12 priority pathogens in research and development and nine institutions participating in mRNA Access. It reports 11,891 mt CO2e of Scope 1 emissions and 9,880 mt CO2e of location-based Scope 2 emissions, while reaffirming its commitment to achieve net-zero Scope 1 and 2 emissions by 2030. The report also presents disclosures under SASB and GRI and states that ERM CVS provided limited assurance according to ISAE 3000 for metrics on page 34.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services